The Genomics of Mouse Milk Lipid Synthesis
Margaret (Peggy) Neville - University of Colorado at Denver and Health Science Center
Mouse milk, like human milk, contains substantial quantities of long
chain polyunsaturated fatty acids (LC-PUFA). The same is not true
of cow milk as shown by the following table:
| Fatty Acid |
Human Milk* |
Bovine Milk |
Mouse Milk |
|---|---|---|---|
| 18:3 n-6 (Linolenic) | 0.37 |
0.30 |
0.01 |
| 20:4 n-6 (Arachadonic) |
0.47 |
0.20 | 1.76 |
| 20:5 n-3 (Eicosapentanoic) |
0.05 |
0.08 | 0.38 |
| 22:6 n-3 (DHA-docosahexanoic acid) |
0.23 |
0.23 | 0.54 |
All data expressed as wt%
*On a Western diet with small quantities of fish oils.
The question is whether these fatty acids are synthesized in the
mammary gland or are transported from the liver. Analysis of
expression arrays during secretory differentiation and activation
suggests that enzymes for elongation and desaturation of fatty acids
are present in the mouse mammary gland and that they are turned on at
the onset of lactation. Further, the genes for fatty acid
synthesis in general are much higher in the mammary gland than in the
liver; e.g. fatty acid synthase is expressed at a level 186 times
higher in the mammary gland than the liver and elongation (Evolve 1)
and desaturation (FADS 1) genes are expressed at levels three times
their levels in the liver. By contrast, many cholesterol synthesis
genes are expressed at higher levels in the liver than the mammary
gland, suggesting that cholesterol is synthesized in the liver and
transported to the mammary gland. One implication of these
observations is that it might be possible to genetically modify the
mammary glands of dairy species to secrete higher concentrations of
LC-PUFA, which would be advantageous for human diets. Supported
by P01 HD38129 to MCN.

